Tom Lesluyes

2.4k total citations · 1 hit paper
38 papers, 816 citations indexed

About

Tom Lesluyes is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Tom Lesluyes has authored 38 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Tom Lesluyes's work include Sarcoma Diagnosis and Treatment (20 papers), Cancer Genomics and Diagnostics (11 papers) and Vascular Tumors and Angiosarcomas (6 papers). Tom Lesluyes is often cited by papers focused on Sarcoma Diagnosis and Treatment (20 papers), Cancer Genomics and Diagnostics (11 papers) and Vascular Tumors and Angiosarcomas (6 papers). Tom Lesluyes collaborates with scholars based in France, United Kingdom and United States. Tom Lesluyes's co-authors include Frédéric Chibon, Peter Van Loo, Sophie Le Guellec, Jean‐Michel Coindre, Gaëlle Pérot, Lucile Delespaul, Luminita Paraoan, Kasit Chatsirisupachai, João Pedro de Magalhães and Timothy L. Bailey and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Tom Lesluyes

36 papers receiving 802 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A pan-cancer compendium of chromosomal instability

2022 135 citations Ruben M. Drews, Bárbara Hernando et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Lesluyes France	18	353	325	280	230	86	38	816
Raphaela Schwentner Austria	19	565 1.6×	344 1.1×	222 0.8×	276 1.2×	122 1.4×	30	1.0k
Ana Cristina Vargas Australia	17	637 1.8×	254 0.8×	376 1.3×	472 2.1×	98 1.1×	36	1.1k
Vanessa Cerisano Italy	11	396 1.1×	318 1.0×	183 0.7×	163 0.7×	94 1.1×	11	750
Gunhild Jug Austria	16	503 1.4×	426 1.3×	255 0.9×	174 0.8×	140 1.6×	23	907
Ana Teresa Amaral Spain	13	317 0.9×	244 0.8×	206 0.7×	150 0.7×	69 0.8×	20	633
Henrik Lilljebjörn Sweden	22	588 1.7×	251 0.8×	338 1.2×	264 1.1×	124 1.4×	51	1.6k
Aaron M. Gruver United States	16	329 0.9×	194 0.6×	376 1.3×	162 0.7×	101 1.2×	38	762
Alessandra Bisagni Italy	16	172 0.5×	259 0.8×	285 1.0×	124 0.5×	134 1.6×	51	765
Badreddin Edris United States	11	390 1.1×	259 0.8×	318 1.1×	269 1.2×	77 0.9×	17	951
Mirjam F. Mastik Netherlands	14	233 0.7×	283 0.9×	175 0.6×	118 0.5×	97 1.1×	28	656

Countries citing papers authored by Tom Lesluyes

Since Specialization

Citations

This map shows the geographic impact of Tom Lesluyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Lesluyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Lesluyes more than expected).

Fields of papers citing papers by Tom Lesluyes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Lesluyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Lesluyes. The network helps show where Tom Lesluyes may publish in the future.

Co-authorship network of co-authors of Tom Lesluyes

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Lesluyes. A scholar is included among the top collaborators of Tom Lesluyes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Lesluyes. Tom Lesluyes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baker, Toby M., Tom Lesluyes, Haixi Yan, et al.. (2024). The History of Chromosomal Instability in Genome-Doubled Tumors. Cancer Discovery. 14(10). 1810–1822. 1 indexed citations

Lesluyes, Tom, Toby M. Baker, Maxime Tarabichi, et al.. (2024). Reconstructing oral cavity tumor evolution through brush biopsy. Scientific Reports. 14(1). 22591–22591.

Pourebrahim, Rasoul, Hiroki Akiyama, Muharrem Müftüoğlu, et al.. (2024). Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice. Cell Reports Medicine. 5(5). 101558–101558. 3 indexed citations

Michot, Audrey, Pauline Lagarde, Tom Lesluyes, et al.. (2023). Analysis of the Peritumoral Tissue Unveils Cellular Changes Associated with a High Risk of Recurrence. Cancers. 15(13). 3450–3450.

Drews, Ruben M., Bárbara Hernando, Maxime Tarabichi, et al.. (2022). A pan-cancer compendium of chromosomal instability. Nature. 606(7916). 976–983. 135 indexed citations breakdown →

Pérot, Gaëlle, Sophie Le Guellec, Nelly Desplat, et al.. (2021). ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas. Cancers. 13(9). 2151–2151. 9 indexed citations

Lesluyes, Tom & Frédéric Chibon. (2020). A Global and Integrated Analysis of CINSARC-Associated Genetic Defects. Cancer Research. 80(23). 5282–5290. 11 indexed citations

Lesluyes, Tom, Christine Ménétrier‐Caux, Mehdi Brahmi, et al.. (2020). Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma. OncoImmunology. 9(1). 1792036–1792036. 30 indexed citations

Filleron, Thomas, Sophie Le Guellec, Christine Chevreau, et al.. (2020). Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial. BMC Cancer. 20(1). 716–716. 9 indexed citations

10.

Croce, Sabrina, Tom Lesluyes, Carine Valle, et al.. (2019). The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas. Clinical Cancer Research. 26(4). 855–861. 15 indexed citations

11.

Delcroix, Vanessa, Tom Lesluyes, Gaëlle Pérot, et al.. (2019). Recurrent DMD Deletions Highlight Specific Role of Dp71 Isoform in Soft-Tissue Sarcomas. Cancers. 11(7). 922–922. 13 indexed citations

12.

Brulard, Céline, Tom Lesluyes, Vanessa Delcroix, et al.. (2019). RCBTB1 Deletion Is Associated with Metastatic Outcome and Contributes to Docetaxel Resistance in Nontranslocation-Related Pleomorphic Sarcomas. Cancers. 11(1). 81–81. 4 indexed citations

13.

Jakob, Jens, Tom Lesluyes, Anna Simeonova-Chergou, et al.. (2019). Impact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03). Strahlentherapie und Onkologie. 196(3). 280–285. 1 indexed citations

14.

Lesluyes, Tom, Jessica Baud, Gaëlle Pérot, et al.. (2019). Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas. Modern Pathology. 32(12). 1786–1794. 28 indexed citations

15.

Millet, Virginie, Thomas Gensollen, Thien‐Phong Vu Manh, et al.. (2018). Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activity. Life Science Alliance. 1(4). e201800073–e201800073. 24 indexed citations

16.

Hemming, Matthew L., Matthew A. Lawlor, Rhamy Zeid, et al.. (2018). Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome. Proceedings of the National Academy of Sciences. 115(25). E5746–E5755. 26 indexed citations

17.

Dumay‐Odelot, Hélène, Nicolas J. Tourasse, Delphine Allard, et al.. (2017). Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements. Cell Cycle. 17(5). 605–615. 18 indexed citations

18.

Lesluyes, Tom, Lucile Delespaul, Jean‐Michel Coindre, & Frédéric Chibon. (2017). The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms. Scientific Reports. 7(1). 5480–5480. 20 indexed citations

19.

Delespaul, Lucile, Tom Lesluyes, Gaëlle Pérot, et al.. (2016). Recurrent TRIO Fusion in Nontranslocation–Related Sarcomas. Clinical Cancer Research. 23(3). 857–867. 31 indexed citations

20.

Lesluyes, Tom, James Johnson, Philip Machanick, & Timothy L. Bailey. (2014). Differential motif enrichment analysis of paired ChIP-seq experiments. BMC Genomics. 15(1). 752–752. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact